Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model

Mark Ramirez, Norma Magee, Dayna Diven, Maria Colome-Grimmer, Massoud Motamedi, Gisele Oliveira, Jesus G. Zamora, Tatsuo Uchida, Richard Wagner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND: Lasers are a commonly employed method of tattoo removal; however, numerous treatments are often needed and laser treatment may fail to eliminate the tattoo completely. It has been shown in animal studies that topical application of imiquimod cream, alone, fades tattoos. It is suspected that the combination of both imiquimod and laser treatment will result in enhanced tattoo pigment clearance. OBJECTIVE: The objective was to evaluate the efficacy of topical imiquimod cream as an adjuvant to laser removal of mature tattoos. METHODS: Fourteen albino guinea pigs were tattooed with black ink, then randomly assigned into two groups: one underwent sequential laser treatments with a Q-switched alexandrite laser in conjunction with triweekly applications of 5% imiquimod cream, while the other group underwent laser therapy alone. Subjects were evaluated with clinical photographs and skin biopsies after six laser treatment sessions. RESULTS: The combination laser and imiquimod treated group was clinically and histologically rated as having less pigment than the tattoos that were treated with laser alone (p=.012 and p=.047, respectively). Adjuvant imiquimod treatment had greater inflammation (p=.002) and fibrosis (p=.002) on posttreatment skin biopsies. CONCLUSION: Imiquimod appears to be a useful adjuvant to experimental laser tattoo removal in guinea pigs.

Original languageEnglish (US)
Pages (from-to)319-325
Number of pages7
JournalDermatologic Surgery
Volume33
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

imiquimod
Lasers
Animal Models
Guinea Pigs
Therapeutics
Biopsy
Skin
Ink
Solid-State Lasers
Laser Therapy

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model. / Ramirez, Mark; Magee, Norma; Diven, Dayna; Colome-Grimmer, Maria; Motamedi, Massoud; Oliveira, Gisele; Zamora, Jesus G.; Uchida, Tatsuo; Wagner, Richard.

In: Dermatologic Surgery, Vol. 33, No. 3, 03.2007, p. 319-325.

Research output: Contribution to journalArticle

Ramirez, M, Magee, N, Diven, D, Colome-Grimmer, M, Motamedi, M, Oliveira, G, Zamora, JG, Uchida, T & Wagner, R 2007, 'Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model', Dermatologic Surgery, vol. 33, no. 3, pp. 319-325. https://doi.org/10.1111/j.1524-4725.2007.33067.x
Ramirez, Mark ; Magee, Norma ; Diven, Dayna ; Colome-Grimmer, Maria ; Motamedi, Massoud ; Oliveira, Gisele ; Zamora, Jesus G. ; Uchida, Tatsuo ; Wagner, Richard. / Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model. In: Dermatologic Surgery. 2007 ; Vol. 33, No. 3. pp. 319-325.
@article{d0be3b70efa343eb8660dedbf1f14ae3,
title = "Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model",
abstract = "BACKGROUND: Lasers are a commonly employed method of tattoo removal; however, numerous treatments are often needed and laser treatment may fail to eliminate the tattoo completely. It has been shown in animal studies that topical application of imiquimod cream, alone, fades tattoos. It is suspected that the combination of both imiquimod and laser treatment will result in enhanced tattoo pigment clearance. OBJECTIVE: The objective was to evaluate the efficacy of topical imiquimod cream as an adjuvant to laser removal of mature tattoos. METHODS: Fourteen albino guinea pigs were tattooed with black ink, then randomly assigned into two groups: one underwent sequential laser treatments with a Q-switched alexandrite laser in conjunction with triweekly applications of 5{\%} imiquimod cream, while the other group underwent laser therapy alone. Subjects were evaluated with clinical photographs and skin biopsies after six laser treatment sessions. RESULTS: The combination laser and imiquimod treated group was clinically and histologically rated as having less pigment than the tattoos that were treated with laser alone (p=.012 and p=.047, respectively). Adjuvant imiquimod treatment had greater inflammation (p=.002) and fibrosis (p=.002) on posttreatment skin biopsies. CONCLUSION: Imiquimod appears to be a useful adjuvant to experimental laser tattoo removal in guinea pigs.",
author = "Mark Ramirez and Norma Magee and Dayna Diven and Maria Colome-Grimmer and Massoud Motamedi and Gisele Oliveira and Zamora, {Jesus G.} and Tatsuo Uchida and Richard Wagner",
year = "2007",
month = "3",
doi = "10.1111/j.1524-4725.2007.33067.x",
language = "English (US)",
volume = "33",
pages = "319--325",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Topical imiquimod as an adjuvant to laser removal of mature tattoos in an animal model

AU - Ramirez, Mark

AU - Magee, Norma

AU - Diven, Dayna

AU - Colome-Grimmer, Maria

AU - Motamedi, Massoud

AU - Oliveira, Gisele

AU - Zamora, Jesus G.

AU - Uchida, Tatsuo

AU - Wagner, Richard

PY - 2007/3

Y1 - 2007/3

N2 - BACKGROUND: Lasers are a commonly employed method of tattoo removal; however, numerous treatments are often needed and laser treatment may fail to eliminate the tattoo completely. It has been shown in animal studies that topical application of imiquimod cream, alone, fades tattoos. It is suspected that the combination of both imiquimod and laser treatment will result in enhanced tattoo pigment clearance. OBJECTIVE: The objective was to evaluate the efficacy of topical imiquimod cream as an adjuvant to laser removal of mature tattoos. METHODS: Fourteen albino guinea pigs were tattooed with black ink, then randomly assigned into two groups: one underwent sequential laser treatments with a Q-switched alexandrite laser in conjunction with triweekly applications of 5% imiquimod cream, while the other group underwent laser therapy alone. Subjects were evaluated with clinical photographs and skin biopsies after six laser treatment sessions. RESULTS: The combination laser and imiquimod treated group was clinically and histologically rated as having less pigment than the tattoos that were treated with laser alone (p=.012 and p=.047, respectively). Adjuvant imiquimod treatment had greater inflammation (p=.002) and fibrosis (p=.002) on posttreatment skin biopsies. CONCLUSION: Imiquimod appears to be a useful adjuvant to experimental laser tattoo removal in guinea pigs.

AB - BACKGROUND: Lasers are a commonly employed method of tattoo removal; however, numerous treatments are often needed and laser treatment may fail to eliminate the tattoo completely. It has been shown in animal studies that topical application of imiquimod cream, alone, fades tattoos. It is suspected that the combination of both imiquimod and laser treatment will result in enhanced tattoo pigment clearance. OBJECTIVE: The objective was to evaluate the efficacy of topical imiquimod cream as an adjuvant to laser removal of mature tattoos. METHODS: Fourteen albino guinea pigs were tattooed with black ink, then randomly assigned into two groups: one underwent sequential laser treatments with a Q-switched alexandrite laser in conjunction with triweekly applications of 5% imiquimod cream, while the other group underwent laser therapy alone. Subjects were evaluated with clinical photographs and skin biopsies after six laser treatment sessions. RESULTS: The combination laser and imiquimod treated group was clinically and histologically rated as having less pigment than the tattoos that were treated with laser alone (p=.012 and p=.047, respectively). Adjuvant imiquimod treatment had greater inflammation (p=.002) and fibrosis (p=.002) on posttreatment skin biopsies. CONCLUSION: Imiquimod appears to be a useful adjuvant to experimental laser tattoo removal in guinea pigs.

UR - http://www.scopus.com/inward/record.url?scp=33847333768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847333768&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2007.33067.x

DO - 10.1111/j.1524-4725.2007.33067.x

M3 - Article

VL - 33

SP - 319

EP - 325

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 3

ER -